GIM
IMUX icon

Granahan Investment Management’s Immunic IMUX Stock Holding History

Granahan Investment Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,519
Closed -$4.16M – 206
2018
Q2 		$4.16M Buy
1,519
+128
+9% +$296K 0.25% 112
2018
Q1 		$3.78M Sell
1,391
-527
-27% -$1.21M 0.27% 110
2017
Q4 		$4.56M Buy
1,918
+947
+98% +$2.09M 0.36% 96
2017
Q3 		$1.96M Buy
971
+330
+51% +$431K 0.16% 140
2017
Q2 		$744K Buy
+641
New +$856K 0.07% 160

Other funds holding IMUX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Granahan Investment Management's IMUX Position: Q3 2018 in Review

Granahan Investment Management sold out of Immunic (IMUX) in Q3 2018, closing a stake of 1,519 shares — an estimated $4.16M sold.

Granahan Investment Management first reported a position in IMUX in Q2 2017 and held it in 5 quarters. The position peaked at $4.56M in Q4 2017. 54 funds tracked by Wall St. Rank hold IMUX as of Q3 2018.

  • Granahan Investment Management reported no remaining Immunic position as of Q3 2018 after selling out during the quarter.
  • Granahan Investment Management sold 1,519 Immunic shares in Q3 2018, an estimated $4.16M.
  • Granahan Investment Management first reported a position in Immunic in Q2 2017 and held it in 5 quarters.
  • Granahan Investment Management's Immunic position peaked at $4.56M in Q4 2017.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q3 2018.

Based on Granahan Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.